A planned Charles Park transaction
The account described Alexandria Real Estate Equities’ intended acquisition of Charles Park One and Two in Kendall Square for $815 million, with a closing expected in December 2021. The office complex was being considered for life-science conversion.
Earlier ownership involved The Davis Companies and Principal Global Investors. The report discussed acquisition financing and leases from that earlier period, rather than today’s ownership and occupancy.
Conversion compared with purpose-built laboratories
The article contrasted adapting existing offices with constructing purpose-built laboratories. Alexandria’s stated approach emphasized strengthening base-building infrastructure within an established laboratory cluster.
The usefulness of an existing office for laboratory work depends on the actual building and intended activities. A proposed conversion or proximity to Kendall Square does not establish that a particular unit has suitable systems or permission.
Other regional examples
The former athenahealth campus in Watertown, a property near Riverside in Newton and the former Landmark Center in Fenway appeared as separate conversion examples. BioMed Realty’s activity at 601 Congress Street in the Seaport was another distinct project.
These comparisons captured the article’s 2021 market discussion. Ask Amo Realty - Boston City Properties about the exact Charles Park or other premises you are considering, with your intended use, area and lease or purchase requirements.
Historical account: Original Boston City Properties report